It would be of interest to analyze the traffic of IgG, therapeutic mAbs (e.g., palivizumab), and other types of immunoglobulins (e.g., IgA and IgM) in polarized cells with trisomy 21. This evidence concerns the gene CD40LG and trisomy 21.